Loading
11:30
  1. Innovating Cell Therapies for Solid Tumours: From Discovery to Clinical Translation
    Advanced Therapies Stage
    30 mins
    Speakers
    Speaker image for Maike de la Roche
    Maike de la Roche, Group Leader -  Cancer Research UK
12:00
  1. Safe by Design: Unbiased Tools for CRISPR Safety in Cell and Gene Therapy
    Advanced Therapies Stage
    30 mins
    Speakers
    Speaker image for Roberto Nitsch
    Roberto Nitsch, Director, Gene Therapy Safety -  AstraZeneca 
12:30
  1. Panel Discussion: Designing for Success: Smarter Preclinical Strategies in Cell & Gene Therapy
    Advanced Therapies Stage
    30 mins
    Speakers
    Speaker image for Azadeh Kia
    Azadeh Kia, VP of Gene Therapy Research - Beacon Therapeutics 
    Speaker image for Trevor Smith
    Trevor Smith, VP of Preclinical R&D - Inovio Pharmaceuticals
    Speaker image for Diana Hernandez
    Diana Hernandez, Director of Immune and Advanced Therapies - Anthony Nolan 
    Speaker image for Leila Abbas
    Leila Abbas, Preclinical Lead - Rinri Therapeutics
13:00
  1. Lunch Break
    Advanced Therapies Stage
    70 mins
14:10
  1. Accelerating Access: Regulatory Support for Advanced Therapies in the UK
    Advanced Therapies Stage
    30 mins
    Speakers
    Speaker image for James Pound
    James Pound, Interim Executive Director of Innovation and Compliance - MHRA
14:40
  1. Panel Discussion: How Do We Design, Execute and Adapt Clinical Trials for One-Time or Personalised Advanced Therapies?
    Advanced Therapies Stage
    60 mins
    Speakers
    Speaker image for Laura Campbell
    Laura Campbell, Chief Medical Officer - Orchard Therapeutics
    Speaker image for Simon Jones
    Simon Jones, Consultant in Paediatric Inherited Metabolic Diseases - Manchester University NHS Foundation Trust
    Speaker image for James Pound
    James Pound, Interim Executive Director of Innovation and Compliance - MHRA
15:40
  1. Networking Break
    Advanced Therapies Stage
    30 mins
16:10
  1. Getting Commissioned ATMPs to Patients: Key Insights
    Advanced Therapies Stage
    30 mins
    Speakers
    Speaker image for Ben Doak
    Ben Doak, Head of Innovative Treatments - NHS England 
16:40
  1. Building the Future of Advanced Therapies: Lessons from the ATTC Network
    Advanced Therapies Stage
    30 mins
    Speakers
    Speaker image for Jacqueline Barry
    Jacqueline Barry, Chief Clinical Officer at Cell and Gene Therapy  - Catapult
17:10
  1. ATMP Engage: Perspectives from People who May Benefit from Advanced Therapies
    Advanced Therapies Stage
    30 mins
    Speakers
    Speaker image for Nick Meade
    Nick Meade, Chief Executive -  Genetic Alliance
11:40
  1. Delivering Gene Therapies Directly to the Brain: A New Frontier for Frontotemporal Dementia
    Advanced Therapies Stage
    30 mins
    Speakers
    Speaker image for William Gray
    William Gray, Professor of Neurosurgery -  Cardiff University
12:10
  1. Advanced Therapies Wales – Driving National Collaboration and Innovation in Advanced Therapy Research and Delivery
    Advanced Therapies Stage
    30 mins
    Speakers
    Speaker image for Steven Conlan
    Steven Conlan, Professor of Molecular and Cell Biology - Swansea University Medical School
12:40
  1. Developing Gene Therapy for Cystic Fibrosis and Other Respiratory Diseases
    Advanced Therapies Stage
    30 mins
    Speakers
    Speaker image for Uta Griesenbach
    Uta Griesenbach, Professor of Molecular Medicine - Imperial College London 
13:10
  1. Lunch Break
    Advanced Therapies Stage
    70 mins
14:20
  1. Addressing Challenges of Advanced Therapies of Rare Diseases
    Advanced Therapies Stage
    30 mins
    Speakers
    Speaker image for Claire Booth
    Claire Booth, Consultant Paediatric Immunologist - Great Ormond Street Hospital
14:50
  1. Horizon Scanning for Advanced Therapies: From Innovation to Patient Access
    Advanced Therapies Stage
    30 mins
    Speakers
    Speaker image for John Spoors
    John Spoors, Programme Director: Commercial, Managed Access and Medicines Policy - NICE
15:20
  1. From Uncertainty to Insight in Advanced Therapies: A Welsh Real-World Data Initiative
    Advanced Therapies Stage
    30 mins
    Speakers
    Speaker image for Hannah Crocker
    Hannah Crocker, Advanced Therapies Outcomes Manager - NHS Wales Joint Commissioning Committee
15:50
  1. Networking Break
    Advanced Therapies Stage
    30 mins
16:20
  1. Panel Discussion: Accelerating Ultra-Personalised Therapies for Rare Genetic Diseases: From Diagnosis to Delivery
    Advanced Therapies Stage
    60 mins
    Speakers
    Speaker image for Deb Lancaster
    Deb Lancaster, Executive Director Scientific Partnership - Genomics England